Chief Financial Officer Samuelson Doug Buys $3,750 Worth of Shares

Kairos Pharma’s Chief Financial Officer, Doug Samuelson, recently made a notable investment in the company by purchasing $3,750 worth of shares. In specific terms, he bought 2,500 units at a price of $1.50. This transaction resulted in an increase in his direct ownership by 4%, bringing his total to 60,796 units. The details of this purchase were disclosed in the Securities and Exchange Commission Form 4 filing on November 22, 2024.

It’s interesting to see key figures within a company like Kairos Pharma showing confidence in its future through personal investments. This move by Samuelson highlights his belief in the company’s potential growth and success.

As per the SEC guidelines, these transactions are required to be transparently reported to ensure accountability and provide investors with valuable information about insider activities in the company. It’s a good practice that adds to the transparency and integrity of the financial markets.

While this news may not impact the day-to-day operations of Kairos Pharma, it does offer a glimpse into the inner workings of the company and the confidence its leadership team has in its trajectory. It’s always encouraging for shareholders to see executives aligning their interests with those of the company and its investors.